Evidence map›Paper›PMID 33256748›Full record

ArticleHealth and quality of life outcomes2020

Health-related quality of life in Marfan syndrome: a 10-year follow-up.

Thy Thy Vanem, Svend Rand-Hendriksen, Cathrine Brunborg, Odd Ragnar Geiran, Cecilie Røe

Open access · goldAbstract read
In one paragraph

Article in Health and quality of life outcomes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Marfan syndrome.Nature reviews. Disease primers · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Thy Thy VanemInstitute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. t.t.vanem@medisin.uio.no.ORCID http://orcid.org/0000-0003-2792-8864
Svend Rand-HendriksenInstitute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Cathrine BrunborgOslo Centre for Biostatistics & Epidemiology, Oslo, Norway.
Odd Ragnar GeiranInstitute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Cecilie RøeInstitute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Oslo University Hospital · NOUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMarfan syndrome, a rare hereditary connective tissue disorder caused by mutations in fibrillin-1, can affect many organ systems, especially the cardiovascular system. Previous research has paid less attention to health-related quality of life and prospective studies on this topic are needed. The aim of this study was to assess changes in health-related quality of life after 10 years in a Norwegian Marfan syndrome cohort.

methodsForty-seven Marfan syndrome patients ≥ 18 years were investigated for all organ manifestations in the 1996 Ghent nosology and completed the self-reported questionnaire, Short-Form-36 Health Survey, at baseline in 2003-2004 and at follow-up in 2014-2015. Paired sample t tests were performed to compare means and multiple regression analyses were performed with age, sex, new cardiovascular and new non-cardiovascular pathology as predictors.

resultsAt 10-year follow-up: a significant decline was found in the physical domain. The mental domain was unchanged. Older age predicted a larger decline in physical health-related quality of life. None of the chosen Marfan-related variables predicted changes in any of the subscales of the Short-Form 36 Health Survey or in the physical or the mental domain.

conclusionKnowledge of decline in the physical domain, not related to organ affections, may be important in the follow-up of Marfan syndrome patients.

Indexed as

Quality of LifeAdultAgedAge FactorsDisease ProgressionFemaleFollow-Up StudiesHumansMaleMarfan SyndromeMiddle AgedNorwaySurveys and QuestionnairesFollow-upHealth-related quality of lifeMarfan syndromeSF-36

Identifiers

PMID33256748
PMCPMC7706277
OpenAlexW3108575024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.